On Monday, May 6, the next meeting of the Transparency Council.
The agenda includes:
1 Prepare an opinion on reimbursement in off-label indications of drugs containing the following active substances:
Agomelatine for the indication: depression or depressive disorders - until the age of 18,
Aripiprazole for the indication: depression or depressive disorders, obsessive-com...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
